CLINUVEL withdraws SCENESSE® label expansion for adolescent erythropoietic protoporphyria 2024 Announcements . Clinical . News 03.06.2024
CLINUVEL and Valentech enter SCENESSE® LATAM partnership 2024 Announcements . Financial . News . Regulatory 23.05.2024
Appendix 3H – Notification of cessation of securities 2024 Announcements . Financial . News . Regulatory 29.04.2024
SCENESSE® European Orphan Drug Designation for Xeroderma Pigmentosum (XP) 2024 Announcements . Financial . News . Regulatory 29.04.2024
Notice of ceasing to be a substantial holder 2024 Announcements . Financial . News . Regulatory 26.04.2024